Sana Biotechnology Inc vs Tractor Supply Co — how do they compare? Sana Biotechnology Inc trades at $2.79 (market cap $836.71M), while Tractor Supply Co trades at $33.7 (market cap $17.44B). The key difference: Tractor Supply Co is far larger — about 20.8× Sana Biotechnology Inc's market cap, and Tractor Supply Co pays a 2.87% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sana Biotechnology Inc for 23 Days and Tractor Supply Co for 89 Days on average.
| SANA | TSCO | |
|---|---|---|
Market Cap | $836.71M | $17.44B |
Volume | 4,507,444 | 10,598,723 |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $56.37 |
52-Week Low | $2.68 | $29.14 |
Typical Hold Time | 23 Days | 89 Days |
Enterprise Value | $749.96M | $23.76B |
Dividend Yield | — | 2.87% |
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $2.79, up 2.57% today, but faces significant fundamental challenges with no revenue, negative earnings, and substantial cash burn. The technical picture remains bearish with moving averages signaling continued downward pressure, though oscillators show neutral conditions. Recent earnings have been mixed with two misses and one beat against expectations, while analyst sentiment remains overwhelmingly positive with 82% buy ratings.
The outlook hinges on SANA's clinical pipeline success and future revenue generation capabilities. Investment opportunity exists in the company's promising biotechnology platform and strong analyst support, but risks include continued cash burn, lack of current revenue, and execution challenges in bringing therapies to market. The stock represents a high-risk, high-reward biotechnology investment.
Tractor Supply (TSCO) trades at $33.48, up 2.95% today, showing resilience after recent earnings misses. The stock maintains a bullish technical outlook with strong moving average signals, though RSI levels suggest potential overbought conditions. Fundamentally, the company demonstrates consistent revenue growth reaching $15.52B in 2025, with healthy profitability metrics including 36.46% gross margin and 39.51% ROE. Recent corporate developments include new distribution center openings and ongoing community investment initiatives.
The investment outlook remains cautiously optimistic with a $36.76 consensus price target representing 9.8% upside potential. Key opportunities include the company's 17-year dividend growth streak and strategic expansion, while risks center on consecutive earnings misses and institutional selling pressure. The balanced analyst coverage (48% buy, 50% hold) reflects uncertainty about near-term performance amid cyclical headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →